Recordati

Shout out to our Italian teams who were recognised at the 2024 Awards for Scientific Information and Patient Centricity! Eccellenze dell'Informazione Scientifica Recordati was one of the top Pharma companies winning first prize in three different categories: RD Italy in the Rare Diseases category, SPC Italy for Traditional Scientific Information and for Chronic Diseases. The award selection process involved a survey of 161,000 doctors to create a shortlist, which was then evaluated by a distinguished board of clinicians, patient association members and scientific societies.   #UnlockingTheFullPotentialOfLife #Recordati

“What unites us: meeting each other, understanding how we work, exploring what we can do differently; working together closely as one Recordati, with one culture, one purpose, and with fantastic performance." This month, our CEO Rob Koremans spent time with the team in Spain, celebrating their contribution and growth journey.   He shared what unites us around the globe as one Recordati, highlighting how meaningful work inspires and empowers us to create a lasting impact. Click below to hear more: #UnlockingTheFullPotentialOfLife #Recordati

Today we announce our 2024 first half results with revenue +13.5%, EBITDA +11.5% and adjusted net income +4.7%. “The strong momentum of the business continued into the second quarter across both Specialty and Primary Care and Rare Diseases. The outlook for the remainder of the year looks equally positive, and we have thus revised upward our guidance for FY 2024. We are excited about the significant opportunities for further growth of our rare Endocrinology and Oncology franchises and the sustainable solid growth of our Specialty & Primary Care portfolio,” commented CEO Rob Koremans. Read full press release here: https://lnkd.in/evwsqZdk #Results #RecordatiResults #H12024

The results of the Patient Partnership Index (PPI) 2024 are in, and the Recordati Rare Diseases team have been awarded finalist, silver and gold status for 3 different projects developed in partnership with patient groups. The PPI recognises and evaluates collaborative projects between the pharmaceutical industry and patient groups, providing an excellent opportunity for reflection and feedback on patient partnership. We are incredibly proud that the team’s work has been recognised as best practice in partnering with the patient community! Read more about the projects: https://lnkd.in/edwAJbgX

“I believe that medicines are more than just products; they are solutions that can make a difference for patients and society" – Ingrida Lurina, Medical Affairs Director (Nordics and Baltics), Recordati Rare Diseases.   Read more below about Ingrida’s role, her dedication to fostering a responsive and collaborative work environment, and her commitment to providing the best solutions for patients. #RecordatiPeople #Recordati #UnlockingTheFullPotentialOfLife

Over the past century, Recordati has continued to adapt and grow to serve the needs of our people and patients, and so has our company identity. These logos trace our history, from our beginnings in a family-run pharmacy in Correggio, Italy, in the 1920s, to the Recordati of today: a global pharmaceutical company with almost 4,500 employees. Each logo marks a step in our journey, as we navigate changing markets and uphold our commitment to health. Today, we stand proud as a company with a long heritage and a clear purpose: Unlocking the full potential of life.   #UnlockingTheFullPotentialOfLife #Recordati

This month, our UK team set off on the Brecon Beacons Four Falls walk in support of the Pituitary Foundation. Covering around 20km, their journey took them through the spectacular woodland scenery of this area, also known as ‘Waterfall Country’. An amazing moment for our team to come together to raise funds for people living with pituitary conditions. The pituitary gland is a small gland at the base of the brain that regulates various hormones. Pituitary conditions disrupt the gland’s functioning, causing excess or insufficient hormone production. This can go on to impact growth, metabolism, and reproductive functions. Together, we’re making strides – both on the trail and for our patient communities. #RecordatiPeople #UnlockingTheFullPotentialOfLife #Fundraising

Our team at Recordati Rare Diseases España has partnered with the non-profit Fundación Juegaterapia (Playtherapy Foundation) to support children receiving treatment for neuroblastoma by introducing the PlayCars project. The project was launched in collaboration with Recordati’s medical team, backed by evidence that video games can significantly reduce discomfort during treatment. The PlayCar station provides access to videogames in the hospital, letting children play while receiving care. So far, five PlayCars are available in hospitals throughout Spain, with plans to expand. The Foundation’s mission is to make the hospital a friendlier place by setting up playrooms or decorating children’s cancer wards. We’re proud of our team for collaborating with Fundación Juegaterapia on this innovative project to help young patients pass the time during their hospital visits.

One year ago, we launched our refreshed purpose: Unlocking the full potential of life. This purpose, co-created with our colleagues, inspires us daily. It drives our commitment to help people be the best version of themselves, whether that is through our work for patients with rare or common diseases or by volunteering in our communities. This drive will never stop. Around 80 of our Culture Ambassadors have worked tirelessly to help our purpose flourish, transforming it from words on paper to a guiding principle throughout Recordati. As we celebrate this milestone, we look forward to continuing to live our purpose and help people live life to the fullest. #Culture #CultureAmbassadors #UnlockingTheFullPotentialOfLife

On World Environment Day we’re delighted to announce that we’re expanding the use of solar power in our plants – continuing our commitment to installing new renewable energy production systems in our manufacturing sites. Following our teams in Spain and Ireland, the Recordati plant in Türkiye is following suit and is now authorised to use its newly completed solar panel system. These solar panels have a maximum power output of around 480 kWp, covering part of the plant's needs. Any further electricity needed for the plant will continue to be purchased from grid, ensuring that it comes from renewable sources. A great example of our sustainability approach through responsible action, protecting our most important assets: people and planet. #WorldEnvironmentDay #Sustainability #PeopleandPlanet